Interim results of clinical study using molecular imaging technology

Montreal, QC July 03, 2003 ART Advanced Research Technologies, a developer of optical molecular imaging technologies, and the McGill University Health Centre have announced interim results of the ongoing SoftScan clinical study.

ART says it has obtained promising preliminary results from the engineering optimization study of SoftScan, currently undergoing at the hospital’s Cedars Breast Clinic. “The preliminary analysis of the clinical study indicates that the SoftScan technology is promising in discriminating between malignant and benign breast lesions,” says Dr David Fleiszer, co-director of the Cedars Breast Clinic and principal investigator of the clinical study.